Risk factors predict microscopic extranodal tumor deposits in advanced stage III colon cancer patients

被引:4
|
作者
Jhuang, Yi-Han [1 ]
Chou, Yu-Ching [2 ]
Lin, Yu-Chun [3 ]
Hu, Je-Ming [4 ]
Pu, Ta-Wei [5 ]
Chen, Chao-Yang [4 ]
机构
[1] Natl Def Med Ctr, Triserv Gen Hosp, Div Cardiovasc Surg, Taipei 114, Taiwan
[2] Natl Def Med Ctr, Sch Publ Hlth, Taipei 114, Taiwan
[3] Natl Def Med Ctr, Triserv Gen Hosp, Dept Pathol, Taipei 114, Taiwan
[4] Natl Def Med Ctr, Triserv Gen Hosp, Div Colorectal Surg, 325 Chang Gong Rd, Taipei 114, Taiwan
[5] Natl Def Med Ctr, Triserv Gen Hosp, Div Colorectal Surg, Song Shan Branch, Taipei 114, Taiwan
关键词
Colon cancer; Tumor deposits; Lymphovascular invasion; Risk factor; COLORECTAL-CANCER; METASTASES; INVASION; IMPACT;
D O I
10.3748/wjg.v29.i11.1735
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUNDColorectal cancer is a frequent cause of cancer-related mortality in patients with lymph node or distant metastases. Pericolonic tumor deposits (TDs) are considered prognostically distinct from lymph node metastases.AIMTo investigate risk factors for extranodal TDs in stage III colon cancer.METHODSThis was a retrospective cohort study. We selected 155 individuals diagnosed with stage III colon cancer from the database of the Cancer Registry of the Tri-Service General Hospital. The patients were allocated into the groups with/without N1c. Multivariate Cox regression analysis and Kaplan-Meier method were done. The primary outcomes investigate the association between the covariates and extranodal TDs, and prognostic significance of the covariates regarding the survival.RESULTSThere were 136 individuals in the non-N1c group and 19 individuals in the N1c group. Patients with lymphovascular invasion (LVI) had a higher risk of TDs. Overall survival rates of patients with and without LVI were 6.64 years and 8.61 years, respectively (P = 0.027). The N1c patients without LVI had higher overall survival than those who with LVI (7.73 years vs 4.42 years, P = 0.010).CONCLUSIONPatients having stage III colon cancer with LVI have a higher probability of having TDs than those with stage III colon cancer without LVI. Stage III colon cancer patients with TDs and LVI could have poor prognosis and outcome.
引用
收藏
页码:1735 / 1744
页数:10
相关论文
共 50 条
  • [31] Factors affecting time to adjuvant chemotherapy in stage III colon cancer patients.
    Holt, A.
    Nelson, R. A.
    Shibata, S.
    Lai, L. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [32] OBSTRUCTIVE COLON CANCER AT ENDOSCOPY AS AN INDEPENDENT RISK PREDICTOR OF ADVANCED TUMOR STAGE AND REDUCED SURVIVAL
    Abu Baker, Fadi
    Ganayem, Mohanad
    Natour, Randa T.
    Beshara, Amani
    Mari, Amir
    Gal, Oren
    Kopelman, Yael
    GASTROINTESTINAL ENDOSCOPY, 2020, 91 (06) : AB459 - AB459
  • [33] PROGNOSTIC FACTORS FOR PATIENTS WITH RECURRENT DISEASE IN STAGE II-III COLON CANCER
    Mateo, Joaquin
    Lopez-Doriga, Adriana
    Navarro, Matilde
    Martinez Villacampa, M. Mercedes
    Laquente, Berta
    Soler, Gemma
    Ramos, Emilio
    Biondo, Sebastiano
    Macia, Ivan
    Salazar, Ramon
    Santos, Cristina
    ANNALS OF ONCOLOGY, 2011, 22 : v107 - v107
  • [34] ASO Author Reflections: The Impact of Tumor Deposits on Survival of Patients with Stage III Colorectal Cancer
    Zheng, Xuzhi
    Ye, Lechi
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : 74 - 74
  • [35] ANALYSIS OF RECURRENCE RISK FACTORS IN PATIENTS WITH STAGE II COLON CANCER.
    Tominaga, T.
    Nagasaki, T.
    Akiyoshi, T.
    Konishi, T.
    Fujimoto, Y.
    Nagayama, S.
    Fukunaga, Y.
    Ueno, M.
    DISEASES OF THE COLON & RECTUM, 2018, 61 (05) : E159 - E159
  • [36] ASO Author Reflections: The Impact of Tumor Deposits on Survival of Patients with Stage III Colorectal Cancer
    Xuzhi Zheng
    Lechi Ye
    Annals of Surgical Oncology, 2024, 31 : 74 - 74
  • [37] Adjuvant chemotherapy for stage III colon cancer patients
    Balakrishnan, L
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (11) : 1496 - 1496
  • [38] Immunomonitoring in patients with stage II and III colon cancer
    Vocka, Michal
    Spacek, Jan
    Netikova, Irena
    Zavadova, Eva
    Nemejcova, Kristyna
    Konopasek, Bohuslav
    Dundr, Pavel
    Geppert, Carol-Immanuel
    Fucikova, Terezie
    Hartmann, Arndt
    Petruzelka, Lubos B.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [39] Readjustment of nodal staging by integrating tumor deposits and positive lymph nodes in patients with stage III colon cancer: a population-based analysis
    Lin, Yi-Hong
    Chen, Qun-Xiang
    Lu, Lin -Bin
    Chen, Hong
    Wu, Jun-Xian
    Wang, Xue-Wen
    Chen, Ya-Ying
    Lin, Qin
    Li, Jie
    Chen, Xi
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (10): : 4976 - 4988
  • [40] Histopathological Predictors of Recurrence in Stage III Colon Cancer: Reappraisal of Tumor Deposits and Tumor Budding Using AJCC8 Criteria
    Landau, Michael A.
    Zhu, Benjamin
    Akwuole, Frances N.
    Pai, Reetesh K.
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2019, 27 (02) : 147 - 158